Uncategorized – Clinical Trial Results

Dr. Stephen Nicholls and Dr. C. Michael Gibson Discuss: SURPASS-CVOT — Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)

November 10, 2025

Disclosures: TBD

Dr. Yohei Sotomi and Dr. C. Michael Gibson Discuss: OPTIMA-AF Trial – Short Dual Antithrombotic Therapy after PCI in Patients with Atrial Fibrillation: OPTIMA-AF trial

November 8, 2025

Disclosures: TBD

Dr. Mary McDermott and Dr. C. Michael Gibson discuss the PERMET trial: Can metformin improve walking performance in nondiabetic patients with peripheral artery disease?

November 8, 2025

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.21358?guestAccessKey=529478e8-ab34-447b-b88f-7fbe78cf4342 © 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar […]

Dr. Pam Taub and Dr. C. Michael Gibson discuss: Effects of Lifestyle and Medical Therapy on Changes in Coronary Atherosclerosis: Tracking Plaque for Personalized Medicine

October 30, 2025

Sponsored by Cleerly, Women as One, and International Atherosclerosis Society

Dr. Robin Nijveldt and Dr. C. Michael Gibson Discuss: iMODERN:iFR- vs. Cardiac MRI-Guided Revascularization of Non-Culprit Lesions in STEMI

October 28, 2025

Disclosures: TBD

Dr. Matthias Bossard and Dr. C. Michael Gibson Discuss: VICTORY:Intravascular Lithotripsy vs. Super-High-Pressure PTCA in Calcified and Refractory Coronary Lesions

October 26, 2025

Disclosures: TBD

Dr. Suzanne J. Baron and Dr. C. Michael Gibson Discuss: Short-CUT: Intravascular Lithotripsy vs. Cutting Balloon Angioplasty in Calcified CAD

October 26, 2025

Disclosures: TBD

Dr. Donald Cutlip and Dr. C. Michael Gibson Discuss: SELUTION4ISR: Sirolimus-Eluting DCB vs. DES or Balloon Angioplasty for In-Stent Restenosis

October 26, 2025

Disclosures: TBD

Dr. Christian M. Spaulding and Dr. C. Michael Gibson Discuss: SELUTION DeNovo: Sirolimus-Eluting DCB vs. DES in De Novo Coronary Lesions

October 26, 2025

Disclosures: TBD

Dr. Marc Bonaca and Dr. C Michael Gibson discuss: When is the world ready for Asymptomatic CAD Screening?

October 20, 2025

Sponsored by Cleerly, Women as One, and International Atherosclerosis Society